Survival analysis showed that a high TRPM2 expression was associated with poor prognosis in KIRC, LGG, OV, THYM, UVM, and LIHC patients (Figure 2) and better prognosis in BLCA, READ, UCEC, THCA, and STAD patients (Supplementary Figure S2). This evidence concerns the gene TRPM2 and gastric adenocarcinoma.